• BIOVAIL CORP Top Competitors

  • Symbol Company Name Last Change % Change Volume News Charts
    BVF BIOVAIL CORP 10.96 -0.06 -0.54 406,757
    LLY LILLY ELI & CO 48.00 0.38 0.80 4.94 M
    TEVA TEVA PHARMACEUTICAL INDS LTD 45.10 -1.43 -3.07 7.63 M
    WPI WATSON PHARMACEUTICALS INC 29.67 -0.35 -1.17 1.02 M
  • Top Competitors Performance Comparison: BVF

      BVF LLY TEVA WPI
    Analyst Recommendation Hold Buy Hold
    Last 10.96 48.00 45.10 29.67
    Change -0.06 0.38 -1.43 -0.35
    EPS (Mean) 3.937 2.717 1.954
    Revenue 18.63 B 9.41 B 2.5 B
    Market Capitalization 1.76 B 54.57 B 36.61 B 3.09 B
    EPS Change vs. Year Ago 11.2147 14.1597 42.6277
    5 Year Annual EPS Growth 1.62624 26.79625 -4.98504
  • Top Competitors Key Measures: BVF

    BVF LLY TEVA WPI
    Valuation
    Price/Earnings (TTM) 19.70 18.30 21.37
    Price/Cash Flow 8.60 10.66 7.86
    Price/Sales (TTM) 3.13 3.79 1.27
    Price/Book 3.93 2.63 1.61
    Per Share Data
    Last Dividend 57.17 14.50 0.00
    Book Value 12.55 19.07 18.29
    EPS (TTM) 0.99 3.21 2.60 1.43
    Revenue 18.63 B 9.4 B 2.49 B
    Profitability
    EBIDTA 5.14 B 3.04 B 514.8 M
    Operating Margin 21.77% 25.46% 12.65%
    Profit Margin 15.85% 20.75% 5.65%
    Gross Profit Margin 77.20% 51.84% 32.66%
    Dividend
    Dividend Yield 3.92% 1.06% 0.00%
    Payout Ratio 57.17 14.50 0.00
    Annual Dividend (TTM) 513.6 M 0.00
    Dividend Yield 5 Year Average 2.62% 0.73% 0.00%
    Growth
    Net Income 2.95 B 1.95 B 141.03 M
    EPS (TTM) 0.99% 3.21% 2.60% 1.43%
    Revenue 18.63 B 9.4 B 2.49 B
    PEG 2.08% 0.96% 0.78%
    Financial Strength
    Quick Ratio (MRQ) 15.85 20.75 5.65
    Current Ratio (MRQ) 3.00 1.84 2.67
    LT Debt to Equity Ratio (MRQ) 31.18 24.39 43.32
    Total Debt to Capital (MRQ) 26.82 27.38 32.87
    ROE 24.92 15.60 7.73
    ROA 14.61 9.67 5.37
    ROIC (Return on Invested Capital) 18.59 11.95 6.00
    Assets
    Asset Turnover 0.70 0.40 0.73
    Asset per Employee 659,798.02956 837,130.61207 604,634.92908
    Inventory Turnover 1.34 1.87 2.83